Hongkai Wang
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Early matched comparison of a novel modular carina robotic platform and the da vinci system for robot-assisted radical prostatectomy.
Journal: Journal of robotic surgery
Published: May 29, 2026
Consolidative therapy for PSMA-avid lesions after 3 cycles of apalutamide plus androgen deprivation in metastatic hormone-sensitive prostate cancer: A prospective phase 2 single-arm trial.
Journal: European journal of nuclear medicine and molecular imaging
Published: February 20, 2026
Plasma Proteomic Profiling Was Used to Discover a Biochemical Recurrence Prediction Model for Prostate Cancer.
Journal: Molecular & cellular proteomics : MCP
Published: May 19, 2025
Lower Testosterone Level and Metastases-Free Survival in Patients With Nonmetastatic Castration-Resistant Prostate Cancer Treated With Novel Antiandrogens: A Post Hoc Analysis of SPARTAN and ARAMIS.
Journal: The Journal of urology
Published: March 25, 2025
Early clinical experience with the Carina robotic platform in urologic surgery.
Journal: BJUI compass
Published: March 02, 2025
Homologous recombination repair gene alteration is strongly associated with more prostate-specific membrane antigen-positive metastases in newly diagnosed hormone-sensitive prostate cancer with ≤5 conventional imaging defined distant metastases.
Journal: European journal of nuclear medicine and molecular imaging
Published: February 03, 2025
Patient-reported outcomes of rezvilutamide versus bicalutamide in combination with androgen deprivation therapy in high-volume metastatic hormone-sensitive prostate cancer patients (CHART): a randomized, phase 3 study.
Journal: Signal transduction and targeted therapy
Published: June 05, 2024
New surgical robotic platforms in China and their applications in urologic surgeries.
Journal: Asian journal of urology
Published: January 06, 2024
Protocol for CHAMPION study: a prospective study of maximal-cytoreductive therapies for patients with de novo metastatic hormone-sensitive prostate cancer who achieve oligopersistent metastases during systemic treatment with apalutamide plus androgen deprivation therapy.
Journal: BMC cancer
Published: December 15, 2023
Development and validation of a nomogram (APGRC) to predict the presence of germline DNA damage repair pathogenic variants in Asian patients with prostate cancer.
Journal: Clinical and translational medicine
Published: June 10, 2023
Fat Attenuation Index of Renal Cell Carcinoma Reveals Biological Characteristics and Survival Outcome.
Journal: Frontiers in oncology
Published: September 30, 2021
Identification of tumor-infiltrating immune cells and prognostic validation of tumor-infiltrating mast cells in adrenocortical carcinoma: results from bioinformatics and real-world data.
Journal: Oncoimmunology
Published: September 14, 2020
Last Updated: 09/26/2026